497 related articles for article (PubMed ID: 32494004)
1. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis.
Zhang ZY; Gao XH; Ma MY; Zhao CL; Zhang YL; Guo SS
Sci Rep; 2020 Jun; 10(1):9024. PubMed ID: 32494004
[TBL] [Abstract][Full Text] [Related]
2. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.
Pang W; Huang F; Zhang X; Ye M; Huang Y; Huang X; Pang J; Cai C; Wang Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32293004
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
[TBL] [Abstract][Full Text] [Related]
5. CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR-433-3p in non-small cell lung cancer.
Yu J; Zhang H; Zhao C; Li G; Zhang Y; Sun Y
Thorac Cancer; 2022 Jan; 13(2):162-172. PubMed ID: 34850570
[TBL] [Abstract][Full Text] [Related]
6. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
Song HM; Meng D; Wang JP; Zhang XY
Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
Wan J; Hao L; Zheng X; Li Z
Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4.
Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F
J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863
[TBL] [Abstract][Full Text] [Related]
11. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
Wei D; Sun L; Feng W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
[TBL] [Abstract][Full Text] [Related]
13. CircRNA_010763 promotes growth and invasion of lung cancer through serving as a molecular sponge of miR-715 to induce c-Myc expression.
Zhang P; Xue XF; Ling XY; Yang Q; Yu Y; Xiao J; Wang ZN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7310-7319. PubMed ID: 32706069
[TBL] [Abstract][Full Text] [Related]
14. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.
Wang Y; Zang RK; Du YN
J Biol Regul Homeost Agents; 2020; 34(6):2037-2047. PubMed ID: 33348975
[TBL] [Abstract][Full Text] [Related]
15. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs.
Zhang Y; Zeng S; Wang T
Bioengineered; 2021 Dec; 12(2):12767-12777. PubMed ID: 34747300
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.
Xu P; Wang L; Xie X; Hu F; Yang Q; Hu R; Jiang L; Ding F; Mei J; Liu J; Xiao H
Aging (Albany NY); 2020 Nov; 12(23):23836-23848. PubMed ID: 33221767
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
Gao P; Wang Z; Hu Z; Jiao X; Yao Y
J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.
Mo WL; Deng LJ; Cheng Y; Yu WJ; Yang YH; Gu WD
Aging (Albany NY); 2021 Apr; 13(8):11629-11645. PubMed ID: 33879631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
